about
Detailed assessments of childhood adversity enhance prediction of central obesity independent of gender, race, adult psychosocial risk and health behaviors.Participants with Normal Weight or with Obesity Show Different Relationships of 6-n-Propylthiouracil (PROP) Taster Status with BMI and Plasma Endocannabinoids.Impact of weight regain on metabolic disease risk: a review of human trialsCentral obesity as a clinical marker of adiposopathy; increased visceral adiposity as a surrogate marker for global fat dysfunctionPopulation distribution of the sagittal abdominal diameter (SAD) from a representative sample of US adults: comparison of SAD, waist circumference and body mass index for identifying dysglycemia.GPER deficiency in male mice results in insulin resistance, dyslipidemia, and a proinflammatory state.The associations between cardiometabolic risk factors and visceral fat measured by a new dual-energy X-ray absorptiometry-derived method in lean healthy Caucasian women.Protopanaxatriol, a novel PPARĪ³ antagonist from Panax ginseng, alleviates steatosis in mice.Mass spectrometry and inflammation--MS methods to study oxidation and enzyme-induced changes of phospholipids.CD36 binds oxidized low density lipoprotein (LDL) in a mechanism dependent upon fatty acid bindingMangiferin supplementation improves serum lipid profiles in overweight patients with hyperlipidemia: a double-blind randomized controlled trial.Ethnic differences in associations between fat deposition and incident diabetes and underlying mechanisms: the SABRE study.Prognostic value of cerebrospinal fluid free fatty acid levels in patients with acute ischemic stroke.Ginsenoside Rb1 ameliorates liver fat accumulation by upregulating perilipin expression in adipose tissue of db/db obese mice.Insulin Resistance of Normal Weight Central Obese Adolescents in Korea Stratified by Waist to Height Ratio: Results from the Korea National Health and Nutrition Examination Surveys 2008-2010.[Factors associated with abdominal obesity in children].Downregulation of de Novo Fatty Acid Synthesis in Subcutaneous Adipose Tissue of Moderately Obese Women.Diet-Induced Obesity and Its Differential Impact on Periodontal Bone Loss.Acyl CoA synthetase 5 (ACSL5) ablation in mice increases energy expenditure and insulin sensitivity and delays fat absorptionNigerian Honey Ameliorates Hyperglycemia and Dyslipidemia in Alloxan-Induced Diabetic Rats.Gender and urban-rural difference in anthropometric indices predicting dyslipidemia in Chinese primary school children: a cross-sectional study.Metabolomic profiling to dissect the role of visceral fat in cardiometabolic healthPostmenopausal Women Have Higher HDL and Decreased Incidence of Low HDL than Premenopausal Women with Metabolic Syndrome.Ginseng extracts restore high-glucose induced vascular dysfunctions by altering triglyceride metabolism and downregulation of atherosclerosis-related genes.Autologous subcutaneous adipose tissue transplants improve adipose tissue metabolism and reduce insulin resistance and fatty liver in diet-induced obesity ratsRelevance of Mediterranean diet and glucose metabolism for nephrolithiasis in obese subjects.Adipocyte pseudohypoxia suppresses lipolysis and facilitates benign adipose tissue expansion.Glucocorticoid hormones and energy homeostasis.Chronic vitamin A-enriched diet feeding induces body weight gain and adiposity in lean and glucose-intolerant obese rats of WNIN/GR-Ob strain.Insulin and the Brain: A Sweet Relationship With Intensive Care.Genetic regulation of adipose tissue transcript expression is involved in modulating serum triglyceride and HDL-cholesterol.Hypoxia in Obesity and Diabetes: Potential Therapeutic Effects of Hyperoxia and Nitrate.Systemic and Local Adipose Tissue in Knee Osteoarthritis.Glutaredoxin-1 Deficiency Causes Fatty Liver and Dyslipidemia by Inhibiting Sirtuin-1.Effect of soy on metabolic syndrome and cardiovascular risk factors: a randomized controlled trial.Altered skeletal muscle fatty acid handling is associated with the degree of insulin resistance in overweight and obese humans.Normobaric hypoxic conditioning to maximise weight-loss and ameliorate cardio-metabolic health in obese populations: A systematic review.Isoflavone supplementation in postmenopausal women does not affect leukocyte LDL receptor and scavenger receptor CD36 expression: A double-blind, randomized, placebo-controlled trial.Intramyocellular Ceramides: Subcellular Concentrations and Fractional De Novo Synthesis in Postabsorptive Humans.Subcutaneous Adipocyte Lipolysis Contributes to Circulating Lipid Levels.
P2860
Q33652760-D1FE4ACF-8EA6-499C-8404-B3A09BE7DEE4Q33683756-1C0BB0B9-D14B-4B0B-A2A4-E921025B6255Q34101121-C5118776-421A-4D47-B36A-B99300BFEE89Q34134296-745E4B11-EFF8-4F9C-A347-2DF2909BBF47Q34278227-807AE257-881A-44C6-9CAF-FA62BDD0F535Q34366110-53B07E7C-16B8-487F-896C-7CDD206BDD96Q34375402-6904FD4B-49D5-4060-A9EA-CA08843019DEQ34659350-FB428000-4C08-4F0A-9D79-177950EEA99AQ35074231-5D091378-D3A9-46C2-A1EF-88BF68961E3DQ35103875-D452306C-7620-423B-9E1D-382C332F19F7Q35623367-D62D6131-F71E-49CB-8CE2-B928CAF16B7DQ35724157-70394052-62AE-4A9D-96F7-578FD247F61BQ35847664-179EDB98-13BD-4A41-9FBB-DCE9561D10F2Q35863097-5EE999A7-DC9F-4312-A037-6AA822D35DFEQ35901476-A55EE7A9-9AF6-4E35-B831-8803A77D3D52Q36388669-37222B1B-FD37-4223-99BE-AE3196DAE58AQ36404304-E6989B13-F08D-4BDA-A242-636113210859Q36485310-784A3975-78E8-417C-B15C-58A8E4DC3F9AQ36628034-8F4E56D8-411E-4D70-80FA-DC516520253AQ36731956-417FCD92-43D0-428D-96C1-83CAF2F547E5Q36853803-7BD6204E-8236-418B-A907-066F370A7674Q37023957-AD0201F7-4A48-4D58-9A42-DD0C61EEB4E8Q37069367-03758340-F182-4A49-95F4-B4AA422E3FC4Q37249857-05273F80-452F-4091-9406-B16C465716C2Q37263899-AC2DA284-82A9-496B-A639-4425C676464AQ37580584-ECFE5619-0DCC-4D0E-AE4A-09F71EF9A987Q37721594-26F36457-0456-4B2C-9FA0-E880739B1E1AQ38267496-64CA0ABF-B5F7-4CB5-AD5E-DF907DC6B7A5Q38299586-68E2A207-4AE2-43B9-A5D7-C5FF6BCCDDF7Q38546134-52D7E90F-B8FC-4999-997E-AA309066A23BQ38606656-B7341157-8D8E-43F1-9B32-F57D8F1C0DFFQ38728642-BB433B6A-E54B-4D9E-894F-C8A65E85DBB0Q39031293-615AD286-A252-43B5-A0FA-6147457FAEF6Q39105659-935085EA-9127-4705-98C9-77CA85B229A6Q39273397-38D263F2-06CD-457C-AAFD-688FEDA09AE2Q39390660-D6884196-D81D-4054-88B9-305AEE5471B5Q39416130-613C7672-4340-4F4C-BA85-7EA6B91BCA74Q39897563-0FC52281-C8AF-471A-92DF-73617E44D160Q40209806-EC661848-2486-4B3B-BFA2-DB12AF9B85BAQ41491014-FAFE38D3-B272-4E7C-AF80-73CA13070B75
P2860
description
2013 nĆ® lÅ«n-bĆ»n
@nan
2013幓ć®č«ę
@ja
2013幓č«ę
@yue
2013幓č«ę
@zh-hant
2013幓č«ę
@zh-hk
2013幓č«ę
@zh-mo
2013幓č«ę
@zh-tw
2013幓č®ŗę
@wuu
2013幓č®ŗę
@zh
2013幓č®ŗę
@zh-cn
name
Fat depots, free fatty acids, and dyslipidemia
@ast
Fat depots, free fatty acids, and dyslipidemia
@en
type
label
Fat depots, free fatty acids, and dyslipidemia
@ast
Fat depots, free fatty acids, and dyslipidemia
@en
prefLabel
Fat depots, free fatty acids, and dyslipidemia
@ast
Fat depots, free fatty acids, and dyslipidemia
@en
P2860
P921
P356
P1433
P1476
Fat depots, free fatty acids, and dyslipidemia
@en
P2093
Jon O Ebbert
Michael D Jensen
P2860
P304
P356
10.3390/NU5020498
P5008
P577
2013-02-07T00:00:00Z